Six Drug Trials at Phase Two or Phase Three

Six drugs (not including Soleno’s DCCR which has progressed past phase 3) are either moving into a phase two or phase three trial. This also includes Carbetocin which has been bought over by Acadia. There is the real prospect of bringing three of those drug trials to the UK.